Dr. Kenneth W. Angermeier, MD

Dr. Angermeier practices at Cleveland Clinic Main Campus in Cleveland, Ohio, part of The Cleveland Clinic Foundation.

Dr. Angermeier's NPI, 1205876729, was assigned on June 7, 2006. Dr. Angermeier graduated from Indiana University School of Medicine in 1985. Dr. Angermeier holds Ohio license 35058385.

Dr. Angermeier's primary practice is Cleveland Clinic Main Campus, at 9500 Euclid Avenue, Cleveland, OH 44195 in Cuyahoga County. The practice phone is (216) 952-9829.

Dr. Angermeier's primary practice is Cleveland Clinic Main Campus in Cleveland, Ohio, part of The Cleveland Clinic Foundation. Dr. Angermeier is also affiliated with Cleveland Clinic Akron General. The medical group on file is Cleveland Clinic. Dmand AI also links Dr. Angermeier to 2 more hospitals and 2 clinical labs, each named with a free account. Dr. Angermeier's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Angermeier practices, 6 sites in all. Vendor and product names are available with a free account.

Urology is Dr. Angermeier's primary specialty in the NPI Registry, under taxonomy code 208800000X. Dr. Angermeier is licensed in Ohio.

CMS data shows 467 Medicare services from Dr. Angermeier across 11 procedure codes in 2024, for 299 Medicare patients. Medicare paid $42,505 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 299 Medicare patients who saw Dr. Angermeier in 2024. The largest group is 65 to 74, with 147 patients. 75% of them have high cholesterol, and 74% have high blood pressure. 4% are also on Medicaid. Their average risk score is 1.37, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Angermeier's median patient age at 70, with 2% women.

In 2024, Dr. Angermeier wrote 205 Medicare Part D claims for 98 patients. 94% of them were for generic drugs. CMS names the drug for 133 of them, across 6 drugs with 11 or more claims each, at $6,956 in total drug cost. In 2023, CMS named 171 claims across 9 drugs.

Dr. Angermeier accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Angermeier as offering telehealth.

Prostate resection: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 13 papers to Dr. Angermeier, published from 2022 to 2024. 2024 was the busiest year, with 5. The most frequent topics are Penile Prosthesis, Postoperative Complications and Urinary Fistula. Dr. Angermeier has published most often in Urology. Dr. Angermeier's most frequent co-authors are Bradley C. Gill, MD, Molly Elmer Dewitt-Foy, MD and Olga Lavryk.

Dmand AI links Dr. Angermeier to 1 clinical trial. 1 is still active or recruiting. Conditions studied include Urethral Stricture and Urethral Obstruction. Open Payments lists research payments to Dr. Angermeier that name 1 trial.

CMS Open Payments shows 111 general payments to Dr. Angermeier from 6 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 73% of the total. Boston Scientific Corporation paid the most, $69,524. It also lists 2 research payments totaling $875 from 2022 to 2025, naming 1 clinical trial.

Dr. Angermeier graduated from Indiana University School of Medicine in 1985.